NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52 | -58.7% | 48,900 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $126 | -77.2% | 48,900 | -63.9% | 0.00% | 0.0% |
Q1 2023 | $552 | +144.2% | 135,300 | +200.0% | 0.00% | 0.0% |
Q4 2022 | $226 | -100.0% | 45,100 | 0.0% | 0.00% | -66.7% |
Q3 2022 | $589,000 | -2.6% | 45,100 | -4.4% | 0.00% | 0.0% |
Q2 2022 | $605,000 | -11.5% | 47,200 | +5.1% | 0.00% | 0.0% |
Q1 2022 | $684,000 | -14.0% | 44,900 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $795,000 | +14.4% | 44,900 | +35.6% | 0.00% | 0.0% |
Q3 2021 | $695,000 | -15.2% | 33,100 | -20.4% | 0.00% | 0.0% |
Q2 2021 | $820,000 | +24.4% | 41,600 | +83.3% | 0.00% | +50.0% |
Q1 2021 | $659,000 | +42.3% | 22,700 | +48.4% | 0.00% | 0.0% |
Q4 2020 | $463,000 | +90.5% | 15,300 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $243,000 | -19.5% | 15,300 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $302,000 | +85.3% | 15,300 | +15.0% | 0.00% | 0.0% |
Q1 2020 | $163,000 | -33.5% | 13,300 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $245,000 | +410.4% | 13,300 | +269.4% | 0.00% | – |
Q3 2019 | $48,000 | +84.6% | 3,600 | +100.0% | 0.00% | – |
Q2 2019 | $26,000 | – | 1,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |